|
SUDS3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.318640E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.206300E-02 |
| Normal-vs-Stage2 |
1.447430E-01 |
| Normal-vs-Stage3 |
1.130250E-01 |
| Normal-vs-Stage4 |
4.479000E-01 |
| Stage1-vs-Stage2 |
9.109800E-01 |
| Stage1-vs-Stage3 |
9.689600E-01 |
| Stage1-vs-Stage4 |
9.472200E-01 |
| Stage2-vs-Stage3 |
8.867400E-01 |
| Stage2-vs-Stage4 |
8.983000E-01 |
| Stage3-vs-Stage4 |
9.647800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.122200E-02 |
| Normal-vs-AfricanAmerican |
8.191800E-01 |
| Normal-vs-Asian |
2.483600E-01 |
| Caucasian-vs-AfricanAmerican |
1.657570E-01 |
| Caucasian-vs-Asian |
8.909200E-01 |
| AfricanAmerican-vs-Asian |
5.213800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.931900E-02 |
| Normal-vs-Female |
4.723600E-01 |
| Male-vs-Female |
4.442000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.040300E-02 |
| Normal-vs-Extreme_Weight |
3.596000E-03 |
| Normal-vs-Obese |
4.671600E-01 |
| Normal-vs-Extreme_Obese |
3.119800E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.952600E-01 |
| Normal_Weight-vs-Obese |
1.661850E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.940400E-01 |
| Extreme_Weight-vs-Obese |
4.222000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.220800E-01 |
| Obese-vs-Extreme_Obese |
5.087600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.851000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.733200E-01 |
| Normal-vs-Age(61-80Yrs) |
5.546200E-02 |
| Normal-vs-Age(81-100Yrs) |
5.979100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.613600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.303400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.037900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.806160E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.035600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.778400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.797000E-01 |
| Normal-VS-Type2 PRCC |
1.441830E-04 |
| Normal-VS-KIRP CIMP |
1.635020E-01 |
| Normal-VS-Unclassified PRCC |
6.812200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.10309999995706E-06 |
| Type1 PRCC-VS-KIRP CIMP |
4.031400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.611000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.479600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.558000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.709200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.161800E-03 |
| Normal-vs-N1 |
5.624200E-01 |
| Normal-vs-N2 |
6.463700E-02 |
| N0-vs-N1 |
2.802300E-02 |
| N0-vs-N2 |
8.278400E-01 |
| N1-vs-N2 |
2.740400E-01 |
|
|
